The Suqian Lakeside Pangu Gene Company in Tianjin, China, has established a new genomics facility for translational medicine research projects and will use the PacBio RS II as its major sequencing platform.
October 29, 2014 |
The Suqian Lakeside Pangu Gene Company in Tianjin, China, has established a new genomics facility for translational medicine research projects and will use the PacBio RS II as its major sequencing platform.
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.